Pfizer to discontinue its GLP-1 pill for obesity due to liver toxicity CEO previously said the company is ‘determined’ to be in obesity

https://www.statnews.com/2025/04/14/pfizer-discontinue-danuglipron-glp-1-obesity-liver-toxicity/